How Is Modern Medicine Being Affected by Drug-Resistant Infections?

Published in: Wellcome website (2021)

Posted on on September 28, 2021

by Lucy Hocking, Gemma-Claire Ali, Camilla d'Angelo, Advait Deshpande, Cagla Stevenson, Mann Virdee, Susan Guthrie

Read More

Access further information on this document at

This article was published outside of RAND. The full text of the article can be found at the link above.

Antimicrobial resistance (AMR) is the ability of microbes (e.g. bacteria, fungi, viruses, parasites) to resist the effects of medications that were once successfully able to kill them or inhibit their growth. This major public health issue could have significant impacts on modern medicine, rendering previously effective treatments no longer useable. Already, we see AMR impacting on our ability to treat certain conditions, but this is projected to grow significantly over the next 20–30 years. The aim of this study is to understand the evidence base regarding the impact of AMR on modern medicine for non-infectious diseases and health conditions. The work consisted of a Rapid Evidence Assessment, which is a standardised and structured approach to searching the literature but has a narrow focus on a topic and is not intended to be a complete systematic review of the evidence-base. This report will be useful for patient advocacy groups, policymakers, health and healthcare research funders and the wider research community.

We looked at academic publications related to impacts of AMR on non-infectious diseases and health conditions published in the last 10 years, identifying a total of 135 articles for inclusion in the review.

Research conducted by

This report is part of the RAND Corporation External publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.

Our mission to help improve policy and decisionmaking through research and analysis is enabled through our core values of quality and objectivity and our unwavering commitment to the highest level of integrity and ethical behavior. To help ensure our research and analysis are rigorous, objective, and nonpartisan, we subject our research publications to a robust and exacting quality-assurance process; avoid both the appearance and reality of financial and other conflicts of interest through staff training, project screening, and a policy of mandatory disclosure; and pursue transparency in our research engagements through our commitment to the open publication of our research findings and recommendations, disclosure of the source of funding of published research, and policies to ensure intellectual independence. For more information, visit

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.